Cargando…

Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors

Metastatic uveal melanoma is a deadly disease with no proven standard of care. Here we present a metastatic uveal melanoma patient with an exceptional high sensitivity to a PD-1 inhibitor associated with outlier CpG>TpG mutation burden, MBD4 germline deleterious mutation, and somatic MBD4 inactiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Manuel, Mobuchon, Lenha, Houy, Alexandre, Fiévet, Alice, Gardrat, Sophie, Barnhill, Raymond L., Popova, Tatiana, Servois, Vincent, Rampanou, Aurore, Mouton, Aurore, Dayot, Stéphane, Raynal, Virginie, Galut, Michèle, Putterman, Marc, Tick, Sarah, Cassoux, Nathalie, Roman-Roman, Sergio, Bidard, François-Clément, Lantz, Olivier, Mariani, Pascale, Piperno-Neumann, Sophie, Stern, Marc-Henri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951831/
https://www.ncbi.nlm.nih.gov/pubmed/29760383
http://dx.doi.org/10.1038/s41467-018-04322-5
_version_ 1783323077746098176
author Rodrigues, Manuel
Mobuchon, Lenha
Houy, Alexandre
Fiévet, Alice
Gardrat, Sophie
Barnhill, Raymond L.
Popova, Tatiana
Servois, Vincent
Rampanou, Aurore
Mouton, Aurore
Dayot, Stéphane
Raynal, Virginie
Galut, Michèle
Putterman, Marc
Tick, Sarah
Cassoux, Nathalie
Roman-Roman, Sergio
Bidard, François-Clément
Lantz, Olivier
Mariani, Pascale
Piperno-Neumann, Sophie
Stern, Marc-Henri
author_facet Rodrigues, Manuel
Mobuchon, Lenha
Houy, Alexandre
Fiévet, Alice
Gardrat, Sophie
Barnhill, Raymond L.
Popova, Tatiana
Servois, Vincent
Rampanou, Aurore
Mouton, Aurore
Dayot, Stéphane
Raynal, Virginie
Galut, Michèle
Putterman, Marc
Tick, Sarah
Cassoux, Nathalie
Roman-Roman, Sergio
Bidard, François-Clément
Lantz, Olivier
Mariani, Pascale
Piperno-Neumann, Sophie
Stern, Marc-Henri
author_sort Rodrigues, Manuel
collection PubMed
description Metastatic uveal melanoma is a deadly disease with no proven standard of care. Here we present a metastatic uveal melanoma patient with an exceptional high sensitivity to a PD-1 inhibitor associated with outlier CpG>TpG mutation burden, MBD4 germline deleterious mutation, and somatic MBD4 inactivation in the tumor. We identify additional tumors in The Cancer Genome Atlas (TCGA) cohorts with similar hypermutator profiles in patients carrying germline deleterious MBD4 mutations and somatic loss of heterozygosity. This MBD4-related hypermutator phenotype may explain unexpected responses to immune checkpoint inhibitors.
format Online
Article
Text
id pubmed-5951831
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-59518312018-05-16 Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors Rodrigues, Manuel Mobuchon, Lenha Houy, Alexandre Fiévet, Alice Gardrat, Sophie Barnhill, Raymond L. Popova, Tatiana Servois, Vincent Rampanou, Aurore Mouton, Aurore Dayot, Stéphane Raynal, Virginie Galut, Michèle Putterman, Marc Tick, Sarah Cassoux, Nathalie Roman-Roman, Sergio Bidard, François-Clément Lantz, Olivier Mariani, Pascale Piperno-Neumann, Sophie Stern, Marc-Henri Nat Commun Article Metastatic uveal melanoma is a deadly disease with no proven standard of care. Here we present a metastatic uveal melanoma patient with an exceptional high sensitivity to a PD-1 inhibitor associated with outlier CpG>TpG mutation burden, MBD4 germline deleterious mutation, and somatic MBD4 inactivation in the tumor. We identify additional tumors in The Cancer Genome Atlas (TCGA) cohorts with similar hypermutator profiles in patients carrying germline deleterious MBD4 mutations and somatic loss of heterozygosity. This MBD4-related hypermutator phenotype may explain unexpected responses to immune checkpoint inhibitors. Nature Publishing Group UK 2018-05-14 /pmc/articles/PMC5951831/ /pubmed/29760383 http://dx.doi.org/10.1038/s41467-018-04322-5 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Rodrigues, Manuel
Mobuchon, Lenha
Houy, Alexandre
Fiévet, Alice
Gardrat, Sophie
Barnhill, Raymond L.
Popova, Tatiana
Servois, Vincent
Rampanou, Aurore
Mouton, Aurore
Dayot, Stéphane
Raynal, Virginie
Galut, Michèle
Putterman, Marc
Tick, Sarah
Cassoux, Nathalie
Roman-Roman, Sergio
Bidard, François-Clément
Lantz, Olivier
Mariani, Pascale
Piperno-Neumann, Sophie
Stern, Marc-Henri
Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
title Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
title_full Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
title_fullStr Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
title_full_unstemmed Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
title_short Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
title_sort outlier response to anti-pd1 in uveal melanoma reveals germline mbd4 mutations in hypermutated tumors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951831/
https://www.ncbi.nlm.nih.gov/pubmed/29760383
http://dx.doi.org/10.1038/s41467-018-04322-5
work_keys_str_mv AT rodriguesmanuel outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT mobuchonlenha outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT houyalexandre outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT fievetalice outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT gardratsophie outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT barnhillraymondl outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT popovatatiana outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT servoisvincent outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT rampanouaurore outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT moutonaurore outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT dayotstephane outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT raynalvirginie outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT galutmichele outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT puttermanmarc outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT ticksarah outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT cassouxnathalie outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT romanromansergio outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT bidardfrancoisclement outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT lantzolivier outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT marianipascale outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT pipernoneumannsophie outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors
AT sternmarchenri outlierresponsetoantipd1inuvealmelanomarevealsgermlinembd4mutationsinhypermutatedtumors